Indian pharma market overview
Indian Pharma Market Overview -2018 1. INDIAN PHARMA SECTOR OVERVIEW - 2018 MR NITESH BHELE 2. INDIAN PHARMA SECTOR OVERVIEW - 2018 Indian pharmaceutical sector is estimated to account for approx. 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. The Indian pharma market, valued at $27 billion, is expected to grow by 1.5 times by 2020. The Indian pharma market will create opportunities for pharma companies to develop diabetic drugs since India is expected to have 100 million diabetic patients by the year 2030. The pharmaceutical industry is also benefiting from the aging U.S population. Overview. In 2002, over 20,000 registered drug manufacturers in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, mostly to the United States and Russia. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Indian market. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK. India contributes the second largest share of pharmaceutical and biotech workforce in the world. The pharmaceutical The Indian pharma market, valued at $27 billion, is expected to grow by 1.5 times by 2020. The Indian pharma market will create opportunities for pharma companies to develop diabetic drugs since India is expected to have 100 million diabetic patients by the year 2030. The pharmaceutical industry is also benefiting from the aging U.S population. Indian pharmaceuticals market is expected to be worth USD 33.18 billion and reach 9th position in the global pharma market by 2023. Based on the overall revenue (except for Piramal where only pharma business division revenue is considered) the top 15 pharmaceutical companies in India are: Sun Pharmaceutical Industries Limited : INR 273.28 Billion Aurobindo Pharma Limited : INR 164.99 Billion
Industry research & analysis report on India's pharmaceutical market from Goldstein Research shows the market to reach USD 76.7 billion by 2024, at a CAGR
Indian Pharma Market Overview -2018 1. INDIAN PHARMA SECTOR OVERVIEW - 2018 MR NITESH BHELE 2. INDIAN PHARMA SECTOR OVERVIEW - 2018 Indian pharmaceutical sector is estimated to account for approx. 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. The Indian pharma market, valued at $27 billion, is expected to grow by 1.5 times by 2020. The Indian pharma market will create opportunities for pharma companies to develop diabetic drugs since India is expected to have 100 million diabetic patients by the year 2030. The pharmaceutical industry is also benefiting from the aging U.S population. Overview. In 2002, over 20,000 registered drug manufacturers in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, mostly to the United States and Russia. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Indian market. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK. India contributes the second largest share of pharmaceutical and biotech workforce in the world. The pharmaceutical
3 May 2004 India's Pharmaceutical Industry: A Growing Influential. Force in the Overview of the Indian pharmaceutical industry: imperatives for the next
India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK. India enjoys an important position in the global Indian pharmaceutical industry Overview and Analysis 2018 PDF PPT is now here ready for you to have a glance. The Indian pharmaceuticals market is the next biggest concerning quantity and thirteenth largest concerning value, according to a report by Equity Master. Market size of the Pharmaceutical Industry in India and Globally (Statista, 2017) In India, the export of drugs is one of the major sources of revenue generation for the pharma industry. The Indian pharma industries are generating almost 55% of their total revenue from exports.
28 Oct 2019 In a report titled 'The Indian pharmaceutical industry – the way Reserve your free place for our latest webinar on 'A 360 overview of data
The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and has significant growth 16 Dec 2019 India: a global pharma powerhouse. India's economy may be struggling, but its pharmaceutical industry is booming, thanks to initiatives to 8 Oct 2019 India's pharmaceutical market grew at its fastest pace in more than a year in the quarter ended September on higher volumes and prices even This report is available to users in India for ₹40,000 + applicable taxes generics, domestic demand to help pharma weather regulated market de-growth 18 Dec 2019 India's pharma market needs to align to Western regulatory standards if the country is to increase its exports, according to experts at CPhI
A document from the Indian Pharmaceutical Alliance (IPA) has outlined the steps that need to be taken by the pharma industry in the country to continue as one of the largest global markets. In a report titled ‘The Indian pharmaceutical industry – the way forward’, the association explains Vision 2030; a plan which defines their growth aspirations.
28 May 2007 ABSTRACT: This paper presents an overview of India's pharmaceutical industry and its evolution from almost non-existent to one of the world's 16 Jul 2019 The Indian pharmaceutical market (IPM) is expected to grow at 9-12 percent compound annual growth rate (CAGR) between 2016-21. Owing to
Market (p. 18). 3) An Overview of the European Generic. Pharmaceutical India: 5 o. EMEA: 3 o. US: 2. ○. Adding divisions of branded companies that are Methods: Indian pharmaceutical market was studied using PharmaTrac, the sales Markets need to be defined carefully for carrying out competition analysis,